α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

Y, Asahina; K, Tsuchiya; T, Nishimura; M, Muraoka; Y, Suzuki; N, Tamaki; Y, Yasui; T, Hosokawa; K, Ueda; H, Nakanishi; J, Itakura; Y, Takahashi; M, Kurosaki; N, Enomoto; M, Nakagawa; S, Kakinuma; M, Watanabe; N, Izumi

doi:10.1002/hep.26442

Public

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

Shared by NobleBlocks on Aug 19, 2013 • 12:00 AM UTC

Authors:

Asahina Y

Tsuchiya K

Nishimura T

Abstract

Unlabelled The effects of interferon (IFN) treatment and the post-IFN treatment α-fetoprotein (AFP) levels on risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC) are unknown. To determine the relationship between AFP and alanine transaminase (ALT) levels and HCC risk, a...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!